Form 8-K - Current report:
SEC Accession No. 0001628280-16-016096
Filing Date
2016-05-10
Accepted
2016-05-10 17:16:08
Documents
4
Period of Report
2016-05-10
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K a8k-ethyolrelease.htm 8-K 20691
2 EXHIBIT 99.1 pressreleaseforethyolrelea.htm EX-99.1 19427
3 clinigen.jpg GRAPHIC 12175
4 cumberland.jpg GRAPHIC 96793
  Complete submission text file 0001628280-16-016096.txt   191380
Mailing Address 2525 WEST END AVENUE SUITE 950 NASHVILLE TN 37203
Business Address 2525 WEST END AVENUE SUITE 950 NASHVILLE, TN 37203 615-255-0068
CUMBERLAND PHARMACEUTICALS INC (Filer) CIK: 0001087294 (see all company filings)

EIN.: 000000000
Type: 8-K | Act: 34 | File No.: 001-33637 | Film No.: 161636859
SIC: 2834 Pharmaceutical Preparations